A Troubling Trend in Employer-Sponsored Health Benefits
Employer-sponsored health plans across the United States are facing a financial reckoning. According to the latest High-Cost Claims and Injectable Drug Trends report from Sun Life U.S., million-dollar health claims have surged by an alarming 46% in recent years. The analysis, drawn from more than 70,000 high-dollar claims submitted by self-funded employers, paints a detailed picture of what is pushing healthcare costs to record-breaking levels — and what plan sponsors, HR leaders, and benefits professionals need to understand to respond effectively.
The findings are not simply about one condition or one treatment. Rather, they reflect a convergence of medical, demographic, and pharmaceutical forces that are reshaping the landscape of employer health benefits. Understanding these drivers is the first step toward building smarter, more resilient benefits strategies.
The Three Primary Drivers Behind Skyrocketing Claims
Sun Life's report identifies three overarching factors that are most responsible for the increase in million-dollar and multimillion-dollar claims.
1. Secondary and Comorbid Conditions
Comorbidities — the presence of two or more chronic or serious conditions in the same patient — have long been a known complicating factor in healthcare, but their impact on claims costs has grown substantially. When a patient presents with multiple diagnoses, treatment plans become more complex, recovery timelines extend, and the likelihood of complications rises. This directly translates into longer hospital stays, more specialist consultations, additional medications, and ultimately, higher total claim values.
The Sun Life data highlights particularly strong connections between cancer, cardiovascular disease, chronic kidney disease, and orthopedic or musculoskeletal (MSK) conditions. These conditions frequently co-occur because they share underlying risk factors, including aging, obesity, diabetes, and systemic inflammation. A cancer patient who also has cardiovascular disease, for example, faces a treatment journey that is exponentially more expensive than managing either condition alone.
2. Long Inpatient Hospitalizations
Extended hospital stays remain one of the most significant cost multipliers in the healthcare system. Inpatient care is resource-intensive by nature, but when patients are admitted for days, weeks, or even months — as is common with premature births, complicated surgeries, or severe infections — costs can escalate rapidly. Intensive care unit (ICU) admissions, specialized nursing, continuous monitoring, and ancillary services all contribute to a daily cost that compounds quickly over extended stays.
For self-funded employers, a single prolonged hospitalization can be enough to push a claim well past the million-dollar threshold, particularly when surgical complications or secondary infections arise during the stay.
3. Injectable and Specialty Drugs
The rising cost of injectable and specialty pharmaceuticals is perhaps the most dynamic driver of high-cost claims. Biologics, monoclonal antibodies, and now gene therapies are revolutionizing treatment outcomes for conditions that were once considered untreatable — but at extraordinary price points. A single course of gene therapy for a rare disease can cost several million dollars, while ongoing injectable treatments for conditions like cancer, autoimmune disorders, or rare genetic conditions can accumulate to seven-figure totals over a plan year.
Injectable drugs are particularly significant because they are frequently administered in clinical settings, compounding both the drug cost and the administration cost. As the pharmaceutical pipeline continues to produce new and highly targeted therapies, this category of spending is expected to grow year over year.
Conditions Most Commonly Linked to Claims Over $3 Million
While all high-cost claims share some common characteristics, the Sun Life report identifies specific conditions that are most frequently associated with claims exceeding $3 million. These include:
- Cancer: A long-standing top driver of multimillion-dollar claims, cancer treatment involves surgery, chemotherapy, radiation, immunotherapy, and increasingly, precision biologics — each with its own significant cost profile.
- Premature birth: Neonatal intensive care for premature infants can generate staggering costs. Extended NICU stays, specialized equipment, and ongoing developmental interventions can push total claims into the millions even for a single patient.
- Orthopedic and musculoskeletal (MSK) conditions: This category represents a newer entrant to the multimillion-dollar claims tier. The report notes that MSK conditions have only recently reached this level of claim severity, suggesting both an increase in condition complexity and the emergence of new, costly treatment options including advanced biologics and surgical interventions.
- Congenital anomalies: Patients born with structural or functional abnormalities often require lifelong, complex care that begins at birth and continues through adulthood.
- Complicated surgeries and gene therapies: Procedures requiring specialized surgical teams, advanced implants, or post-operative intensive care — combined with the rapid introduction of gene-based treatments — are increasingly appearing in the highest cost tiers.
Why Orthopedic and MSK Conditions Deserve Special Attention
One of the more surprising findings in the report is the rapid ascent of orthopedic and musculoskeletal conditions into the multimillion-dollar claims category. Historically, these conditions generated significant but more manageable costs. Their arrival at the top tier reflects two important trends: first, a growing severity of cases, potentially linked to an aging workforce and the increasing prevalence of obesity-related joint disease; and second, the introduction of advanced therapies, including biologic injections, robotic-assisted surgical procedures, and novel implant technologies, each of which carries a premium price tag.
Notably, orthopedic and MSK conditions are also among the most common diagnoses for short-term disability claims, meaning that employers face a dual financial burden — both health insurance costs and productivity loss — when these conditions affect their workforce.
What This Means for Self-Funded Employers
For organizations that self-fund their health benefits, the implications of these trends are direct and immediate. Unlike fully insured plans where the insurer absorbs cost risk, self-funded employers bear the financial exposure of high-cost claims directly. The 46% spike in million-dollar claims is not an abstract statistic — it represents real budget pressure that can affect an organization's bottom line and its ability to sustain competitive benefits offerings.
Proactive strategies are increasingly essential. These may include investing in robust stop-loss coverage, implementing high-cost claimant management programs, expanding access to centers of excellence for complex surgeries, deploying pharmacy benefit management tools that address specialty drug costs, and strengthening disease management and wellness programs designed to reduce the prevalence of comorbid conditions before they escalate.
Looking Ahead: The Imperative for Data-Driven Benefits Strategy
The Sun Life findings underscore a fundamental shift in how employers must approach health benefits planning. Rising healthcare costs are no longer solely driven by utilization volume — they are increasingly shaped by the complexity and severity of individual cases. A single patient with cancer, cardiovascular disease, and a musculoskeletal condition receiving cutting-edge injectable therapies can generate claims that exceed what entire groups generated just a decade ago.
Benefits leaders who leverage detailed claims data, partner with experienced stop-loss carriers, and adopt targeted clinical management programs will be best positioned to navigate this challenging environment. The 46% increase in million-dollar health claims is a wake-up call — and the organizations that respond with strategy rather than surprise will be the ones that protect both their employees and their financial health in the years ahead.